Aagami receives contract extensions from Multiple clients
Aagami is pleased to announce that during the period of July to September, multiple clients have awarded contract extensions to Aagami.
- US based Genetic Engineering company prepared to counter the next Global threat of Autoimmune diseases.
- Biosimilar focused subsidiary of a Global Pharma awards contract extension to Aagami.
- US based client with clinical drug to target MDS and several other indications.